DTx East 2022
5th Annual

DTx East 2022

September 27-29th | Boston, MA

Catalysing the Digital Evolution of Healthcare

 

 

Agenda Register Now for DTx East 2022

Partners

Knowledge Partners
Knowledge Partners

Curebase is a leading provider of decentralized clinical research software and services for digital therapeutics. Curebase enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations. Curebase operates as a complete eClinical software platform, virtual research site, and full-service CRO.

Learn More

Knowledge Partners

We set our sight on a simple, but powerful vision to advance life science services toward a healthier world.

The journey began when Water Street Healthcare Partners and JLL Partners joined forces to acquire and combine the most comprehensive platform of life sciences services in the industry. Together, we are EVERSANA.

We offer more than 500 clients – from start-ups to established global pharmaceutical leaders – the services they need to bring critical therapies to market while improving the lives of patients around the world.

Learn More

Knowledge Partners

IQVIA is a world leader in using data, technology, advanced analytics, and expertise to help customers drive healthcare forward. Together with the companies we serve, we are enabling a more modern and effective healthcare system and creating breakthrough solutions that transform business and patient outcomes.

Learn More

Knowledge Partners

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive.

Learn More

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive.

Learn More

Knowledge Partners

Ieso is a data-driven AI healthcare company pioneering next-generation digital therapeutics to improve mental health outcomes and access to care. 

The company is developing a pipeline of AI-driven evidence-based mental health assessment tools and solutions to democratize access to mental health therapy at scale. With a network of more than 600 fully qualified therapists, ieso provides virtual care (or telehealth) serving more than 20 million adults through the UK National Health Service (NHS), delivering more than 460,000 hours of cognitive behavioral therapy (CBT).

The company has analyzed over 500 million datapoints to decode the active ingredients of therapy to develop scalable digital therapeutics. ieso’s research has been published in several peer-reviewed journals including the Lancet and JAMA, shaping our understanding of scalable digital mental healthcare solutions.

Learn More

Knowledge Partners

SoftServe is a trusted technology advisor and provider. We enable our clients across the healthcare continuum to build transformative patient experiences, gain data insights, and accelerate business outcomes. SoftServe’s experts deliver innovation, quality, and speed built on a foundation of empathetic, human-focused experience design.

Learn More

Summit Partners
Summit Partner

DTxCC: a boutique consultancy focused solely on Digital Therapeutics and Digital Health commercialization

We specialize in go-to-market strategy development:

– Market Access and  Reimbursement
– Business models development
– Data monetization

Our Payer Advisory Council provides actionable insight

Custom qualitative research
– One-one-one interviews

Advisory board meetings
– Virtual
– Live face-to-face meetings

Learn More

Summit Partner

TopLine Power® is what Simon-Kucher is all about. We help clients grow revenue through optimization of strategy, pricing, marketing, and sales across industries.
We are a thought leader in these topics at the intersection of digitalization and life sciences, positioning our clients thrive in the healthcare industry of the future.

Learn More

Supporters
Supporter

At our core is perseverance, a fierce determination to overcome any obstacle regardless of setbacks, on behalf of patients and their loved ones. We place greater value on what we can achieve together than on what we can do alone because the needs of those we serve always come first. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear: Otsuka-people, creating new products for better health worldwide.

Learn More

Supporter

JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.

We seek breakthroughs at the intersection of digital technology and neuroscience that are influencing the human experience, such as augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems.

Our portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.

Learn More

Supporter
Happify Health is The Intelligent Healing Company™. We shorten the distance between need and care by configuring personalized digital therapeutics and care solutions at scale for the modern healthcare cloud. Our platform integrates AI with empathy, making healing more personal, precise, and connected for the entire care journey. We deploy a full spectrum of clinical-grade care solutions—including Digital Therapeutics, Coaching, Community, and Well-being products—for pharma, health plans, enterprises, and individuals everywhere.
Our global platform is available in 10 languages, supports more than 10 chronic conditions, and covers more than 20 million lives.
Supporters

Voluntis is an Aptar Pharma company and part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Voluntis creates digital therapeutics that empower people with chronic conditions to self-manage their treatment every day, thus improving real-world outcomes. Voluntis’ solutions combine mobile and web apps, using clinical algorithms to deliver personalized recommendations to patients and their care teams to adjust treatment dosage, manage side effects or monitor symptoms.

Leveraging its Theraxium technology platform, Voluntis designs digital therapeutics solutions across multiple areas, including oncology and diabetes. Based in Cambridge, MA, and Paris, France, Voluntis is a founding member of the Digital Therapeutics Alliance.

Learn More about Voluntis

Learn More about Aptar

About Us

DTx East 2022 is aligned with the digital therapeutics industry and its efforts establish digital within healthcare.

Dedicated to tackling key challenges around reimbursement, regulation, physician adoption, patient engagement and more, DTx East 2022 is set to empower the experts and catalyze the digital evolution of healthcare.

About Us
DTx East in a Nutshell
East 3 days
Three Full Days of Leading Content

DTx East 2022 is back with a bang! Bringing you 3 full days of cutting-edge content and an industry leading speaker faculty, this event provides you with a one-stop shop of all things digital therapeutics ensuring you leave the event with key takeaways and the knowledge to accelerate your own digital journey. We’ve got a lot to catch up on and DTx East has got you covered!

3 Distanced people
Fully In-Person

The time has come to meet in-person once again! Join your peers for live presentations, engaging discussions and face-to-face networking. Step away from the screen for 3 days of industry-defining discussions and catch up with old and make new connections within the field. With some of the audience tuning in virtually, use our dedicated session to network with industry leaders from across the globe.

DTx East Online Icon
Senior & Multifaceted Community

Experts from every stakeholder within the digital therapeutics space will be descending on Boston in September. Join your peers from leading DTx companies, Pharma, Payers, Providers, Government Bodies, Policy Makers and more!

DTx conferences are excellent places to collaborate with top leaders and stay current on the often complex and evolving trends shaping our investments – all while being part of a passionate, growing community of entrepreneurs.

Elan Tye, Principal, JAZZ Venture Partners

The DTx series is more than a conference – it’s become a community with mutual interest in advancing digital therapeutics.

David Stevenson, Managing Director, Merck Global Health Innovation Fund

The people I have met and the discussions I have had during and between sessions at past in-person DTx events have turned into friendships and business relationships that are the true highlights of the DTx events.. I am really looking forward to being part of the in-person interactions at this year’s DTx East.

Brent Vaughan, CEO, Cognito Therapeutics

DTx West 2021 did not disappoint!  Even though this was a virtual conference the quality of presentations were stellar. Looking forward to DTx East!

Debra Reisenthel, Founding CEO, Freespira
DTx East 2022 Speaker Faculty
Brandon O'Leary
Brandon O'Leary
Acting Director, Digital Health Centre of Excellence
U.S FDA
Brandon O'Leary
Acting Director, Digital Health Centre of Excellence
U.S FDA
Meg Barron
Meg Barron
VP, Digital Health Innovations
American Medical Association
Meg Barron
VP, Digital Health Innovations
American Medical Association

Meg is passionate about driving change by collaborating with physicians, technology leaders and solution innovators to improve health care. She has served in product development and business development leadership roles at the AMA and most recently is responsible for driving the roadmap of initiatives that support the AMA’s digital health and medicine strategy. In addition, she has led partnerships and innovation related initiatives, such as the inaugural AMA Healthier Nation Innovation Challenge, the establishment of the AMA Interaction Studio at MATTER, the AMA Physician Innovation Network that enables entrepreneurs and physicians to collaborate on the development of new solutions, the AMA Digital Health & Telehealth Implementation Playbook series, AMA Digital Health research and The Telehealth Initiative with collaborators. She participates on the Advisory Board for MATTER, MassChallenge HealthTech, HealthTech Arkansas, Together.Health and as a TEDMed Research Scholar. She also participates on the Editorial Review Board of The Telehealth and Medicine Today Journal.

Meg has spoken at national conferences such as Health 2.0, Connected Health, HLTH, American Telemedicine Association National Conference, AMA State Advocacy Conference and contributes as speaking faculty for Columbia Business School’s Digital Health program curriculum. She has articles published in Health Affairs, Harvard Business Review and Nature Digital Medicine.

Prior to AMA, Meg worked in the Consumer Product & Retail vertical at Capgemini and at SmithBucklin Corporation for various business and health care clients.

Joe Powers
Joe Powers
VP & Chief Digital Business Officer
Otsuka Pharmaceutical North America
Joe Powers
VP & Chief Digital Business Officer
Otsuka Pharmaceutical North America
Camille McMullen
Camille McMullen
VP, Government Sales
Freespira
Camille McMullen
VP, Government Sales
Freespira
Everett Crosland
Everett Crosland
Chief Commercial Officer
Cognito Therapeutics
Everett Crosland
Chief Commercial Officer
Cognito Therapeutics
Chris Wasden
Chris Wasden
Chief Strategy Officer
Happify Health
Chris Wasden
Chief Strategy Officer
Happify Health
Anand Iyer
Anand Iyer
Chief Strategy Officer
Welldoc
Anand Iyer
Chief Strategy Officer
Welldoc

Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®. Since joining WellDoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. He holds an MS and a PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University.

Deepti Jaggi
Deepti Jaggi
Chief Strategy & CommercialOfficer
Better Therapeutics
Deepti Jaggi
Chief Strategy & CommercialOfficer
Better Therapeutics
Chuck Gammal
Chuck Gammal
Partner
Simon Kucher & Partners
Chuck Gammal
Partner
Simon Kucher & Partners
Anish Shindore
Anish Shindore
Founder & Managing Partner
GSD Health
Anish Shindore
Founder & Managing Partner
GSD Health
Bryan Stone
Bryan Stone
SVP, Business Development
Universal Music Group
Bryan Stone
SVP, Business Development
Universal Music Group
Kiran Avancha
Kiran Avancha
Chief innovation Officer
HonourHealth
Kiran Avancha
Chief innovation Officer
HonourHealth
Malinda Peeples
Malinda Peeples
SVP, Clinical Services & Research
Welldoc
Malinda Peeples
SVP, Clinical Services & Research
Welldoc
Jay Ahlman
Jay Ahlman
Vice President, CPT Coding and Reimbursement Policy and Strategy
American Medical Association
Jay Ahlman
Vice President, CPT Coding and Reimbursement Policy and Strategy
American Medical Association

Jay Ahlman is Vice President of CPT Coding and Reimbursement Policy and Strategy for the American Medical Association (AMA). Jay joined the AMA in 1999 and has held various roles in healthcare strategy, policy and coding during his tenure.  Since 2008, Jay has led the AMA group responsible for the maintenance of the Current Procedural Terminology (CPT) code set and is the lead staff to the CPT Editorial Panel for the AMA.  During this time Jay has worked with the CPT Editorial Panel to lead many significant changes, including the evolution of CPT Literature Standards and the launch of new CPT coding sections including the Proprietary Laboratory Analyses (PLA) code section.  Jay is also the lead staff to the AMA’s Digital Medicine Payment Advisory Group, which is an advisory body made up of 15 industry experts charged with creating solutions to enable the integration of digital healthcare and telehealth solutions into clinical practice.  Most recently, Jay has been involved in the revision of the CPT Evaluation and Management coding structure and the addition of Remote Physiologic and Remote Therapeutic Monitoring codes to the CPT code set.

Liesl Oldstone
Liesl Oldstone
VP, Health Economics & Market Access
AppliedVR
Liesl Oldstone
VP, Health Economics & Market Access
AppliedVR
Brian Harris
Brian Harris
Co-Founder & CEO
MedRhythms
Brian Harris
Co-Founder & CEO
MedRhythms
Maria Sullivan
Maria Sullivan
VP, Clinical Development
Pear Therapeutics
Maria Sullivan
VP, Clinical Development
Pear Therapeutics
Andy Molnar
Andy Molnar
Chief Executive Officer
Digital Therapeutics Alliance
Andy Molnar
Chief Executive Officer
Digital Therapeutics Alliance
Nick Dougherty
Nick Dougherty
VP, Digital
Allways Health Partners
Nick Dougherty
VP, Digital
Allways Health Partners
Omar Manajwala
Omar Manajwala
Chief Medical Officer
Dario Health
Omar Manajwala
Chief Medical Officer
Dario Health
Amir Lahav
Amir Lahav
Digital Healthcare Innovation, Head of Digital R&D
Mitsubishi Tanabe Pharma Holding America
Amir Lahav
Digital Healthcare Innovation, Head of Digital R&D
Mitsubishi Tanabe Pharma Holding America

Amir is an established neuroscientist specialized in digital medicine and clinical innovation. His strategic vision is empowered by real-world data that enable the discovery of clinical insights otherwise not possible solely based on conventional health records. Amir has boundless passion for accelerating novel therapies and creating a path for better patient experience. He brings an entrepreneurial zeal to the clinical world through disruptive technology and AI analytics from proof of concepts to scale-up solutions. Prior to pharma , Amir was a professor of Pediatrics and Epidemiology at Harvard Medical School and Harvard School of Public Health and served as a PI on numerous clinical trials with 200+ publications and conference presentations.

Risa Weisberg
Risa Weisberg
Chief Medical Officer
BehaVR
Risa Weisberg
Chief Medical Officer
BehaVR

Dr. Risa Weisberg has devoted her career to developing and scientifically testing scalable interventions for common behavioral health problems. Her mission is to expand the reach of high-quality, science-based behavioral health treatment. She has over two decades of research, clinical, and leadership experience which she now brings to lead the clinical direction and research strategy of BehaVR at Chief Clinical Officer. Risa has a doctoral degree in Clinical Psychology from the University at Albany. She completed a doctoral internship and postdoctoral fellowship at Brown University. She is a Professor of Psychiatry at the Boston University School of Medicine and an Adjunct Professor of Family Medicine at the Alpert Medical School of Brown University. She is an expert in cognitive-behavioral therapy and acceptance and commitment therapies. As a primary care psychologist, Risa has broad experience in treatment development and implementation for common behavioral health problems including anxiety, depression, chronic pain, substance use disorder, and adaptation to living with other chronic medical difficulties. Her research has been funded by the National Institutes of Health, the Patient Centered Outcomes Research Institute, the Veterans Administration, and numerous foundations. Risa is a member of the Scientific Council of the Anxiety and Depression Association of America and a Fellow and former Board Member of the Association for Behavioral and Cognitive Therapies.

Sarah Schenck
Sarah Schenck
Medical Director, Virtualist Medicine
ChristianaCare Health System
Sarah Schenck
Medical Director, Virtualist Medicine
ChristianaCare Health System
Sean Kinsman
Sean Kinsman
Chief Clinical Officer
Recovery One
Sean Kinsman
Chief Clinical Officer
Recovery One

Sean Kinsman, DPT serves as the Chief Clinical Officer at RecoveryOne, a leading
digital health innovator dedicated to improving health outcomes for recovery from
musculoskeletal (MSK) injuries of all types and reducing costs. Dr. Kinsman has been
instrumental in driving RecoveryOne’s expansion into clinical care and is the
architect behind their network of clinicians who service patients through their digital
treatment pathways. He is a Board Certified Orthopedic Clinical Specialist.
Prior to joining RecoveryOne, Dr. Kinsman contributed to the world-renowned “MICU
Study” while working in clinical practice at Johns Hopkins Hospital. The study focused
on the early mobilization of medically complicated patients in an intensive care unit
setting. Dr. Kinsman was also a key contributor to Johns Hopkins’ Hemophilia Clinic
and Cystic Fibrosis teams, managing long-term complications in both populations.
Dr. Kinsman’s previous experience also includes serving as part of a multi-
disciplinary team of Stanford physicians where he contributed to the creation of an
innovative, intensive recovery program for patients who developed dependence to
prescription opioids. The program averaged a 76% clinical success rate over six
years.
He previously also served as Clinic Director at Henning and Cole, a group of
outpatient therapy clinics in the Baltimore area. He earned his BS, MA and DPT at
Northeastern University, Boston, MA

Shwen Gwee
Shwen Gwee
VP, Head of Global Digital Strategy
Bristol Myers Squibb
Shwen Gwee
VP, Head of Global Digital Strategy
Bristol Myers Squibb
Steven Driver
Steven Driver
Medical Director, Digital Therapeutics
Advocate Aurora Health
Steven Driver
Medical Director, Digital Therapeutics
Advocate Aurora Health
Ted Burns
Ted Burns
VP, Product
Propeller Health
Ted Burns
VP, Product
Propeller Health

Ted is an experienced media and technology professional with over 25 years of experience in product management and content development. Ted has held various executive, editorial and product management roles at AOL Canada, Yahoo!, and 4INFO where he was Vice President of Products. Starting in 2010 Ted began working as an independent consultant for early-stage companies developing data, online video, and television products and was instrumental in starting RevUp.com, an award-winning company based in Northern California that revolutionized political and non-profit fundraising. Ted is currently working as the Vice President of Product at Propeller Health, one of the top digital health companies in the world that are helping bring connected devices to asthma and COPD patients around the world.

Vandana Menon
Vandana Menon
VP, Clinical Research & Evidence Generation
Akili Interactive
Vandana Menon
VP, Clinical Research & Evidence Generation
Akili Interactive
Ana Maiques
Ana Maiques
Chief Executive Officer
Neuroelectrics
Ana Maiques
Chief Executive Officer
Neuroelectrics

Ana Maiques is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain, developing innovative technologies to monitor and stimulate the brain to help many patients in need. She was nominated by IESE Business School as one of the most influential entrepreneurs under 40 in Spain in 2010. She received the EU Prize for Women Innovators from the European Commission EC in 2014. In 2015 & 2016, she was named one of the most inspiring women on the Inspiring Fifty list in Europe. Ana continues breaking the barriers of science and technology in an impactful way with Business Ethics.

Jeff Howell
Jeff Howell
Head of Design
Eli Lilly & Company
Jeff Howell
Head of Design
Eli Lilly & Company
Jason Parent
Jason Parent
Director, Clinical Innovation
Point32Health
Jason Parent
Director, Clinical Innovation
Point32Health
Brad Van Orden
Brad Van Orden
Director, Digital Medicine & Digital Therapeutics
Bristol Myers Squibb
Brad Van Orden
Director, Digital Medicine & Digital Therapeutics
Bristol Myers Squibb
Tanya Dillard
Tanya Dillard
VP, Strategy & Innovation
Transcarent
Tanya Dillard
VP, Strategy & Innovation
Transcarent
Adam Kundzewicz
Adam Kundzewicz
Executive Director
Boehringer Ingelheim Venture Fund
Adam Kundzewicz
Executive Director
Boehringer Ingelheim Venture Fund
Sarah Cooper
Sarah Cooper
Product Manager
MedRhythms
Sarah Cooper
Product Manager
MedRhythms
Belinda Brummett
Belinda Brummett
Senior Director, Digital Health Engagement, Digital Business
Banner Health
Belinda Brummett
Senior Director, Digital Health Engagement, Digital Business
Banner Health
Dan Rimm
Dan Rimm
Head of Product
Click Therapeutics
Dan Rimm
Head of Product
Click Therapeutics
Michael Malecki
Michael Malecki
Head of Access and Reimbursement
Blue Note Therapeutics
Michael Malecki
Head of Access and Reimbursement
Blue Note Therapeutics
Ronny Hashmonay
Ronny Hashmonay
Global Head of Business Transformation
Novartis
Ronny Hashmonay
Global Head of Business Transformation
Novartis
Julia Strandberg
Julia Strandberg
Chief Commercial Officer
Pear Therapeutics
Julia Strandberg
Chief Commercial Officer
Pear Therapeutics
Charles Haddad
Charles Haddad
AVP, Head of Product Strategy, Global Digital Health
Eli Lilly & Company
Charles Haddad
AVP, Head of Product Strategy, Global Digital Health
Eli Lilly & Company
Mark Zhang
Mark Zhang
Associate Chief Medical Officer, Digital Innovation
Brigham & Women’s Hospital
Mark Zhang
Associate Chief Medical Officer, Digital Innovation
Brigham & Women’s Hospital
Jo Masterson
Jo Masterson
Co-Founder & CEO
2morrow
Jo Masterson
Co-Founder & CEO
2morrow
Faisal Al-Husry
Faisal Al-Husry
Principal
Hikma Ventures
Faisal Al-Husry
Principal
Hikma Ventures
Davide Ricci
Davide Ricci
VP, US Software as a Medical Device/Digital Therapeutics
Novo Nordisk
Davide Ricci
VP, US Software as a Medical Device/Digital Therapeutics
Novo Nordisk

Partner With Us

The DTx summits are the premier event series for senior executives from DTx companies, Pharma, Investors, HCPs, Payers and more.

DTx East 2022 is the 14th summit in the DTx series. The industry leaders and most exciting newcomers will be in attendance across an in-person and online event. 

The DTx series provides a rare opportunity to showcase your business to a world-class audience. Spaces are limited this year, please contact our commercial manager, Sam (sam@greygreenmedia.com), to discuss your bespoke package.

Contact Us +
Partner With Us

Register for the Event

For pricing and booking options for DTx East 2022 please click the button to go to the registration page.

Registration